ACR Consensus Statement: Use of intravenous gadolinium-based contrast media in patients with kidney disease

Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation – Radiology

Commentary on Twitter

The potential harms of delaying or withholding group II GBCM for an MRI likely outweigh the risks of NSF in patients with acute kidney injury or moderate-to-severe loss of kidney function. This study in @radiology_rsna explains why. https://t.co/yZV38mpuLN #AbdRad pic.twitter.com/i46pK2FyB7

— RSNA (@RSNA) December 11, 2020